BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24981880)

  • 1. Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes.
    Yang Z; Chen H; Si H; Li X; Ding X; Sheng Q; Chen P; Zhang H
    Acta Diabetol; 2014 Oct; 51(5):823-31. PubMed ID: 24981880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.
    Kong L; Zhu J; Han W; Jiang X; Xu M; Zhao Y; Dong Q; Pang Z; Guan Q; Gao L; Zhao J; Zhao L
    Acta Diabetol; 2011 Mar; 48(1):61-9. PubMed ID: 20857148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats.
    Vatandoost N; Amini M; Iraj B; Momenzadeh S; Salehi R
    Gene; 2015 Nov; 572(1):95-100. PubMed ID: 26164754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes.
    Yan S; Wang T; Huang S; Di Y; Huang Y; Liu X; Luo Z; Han W; An B
    Acta Diabetol; 2016 Oct; 53(5):693-702. PubMed ID: 27039347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes.
    Al-Kafaji G; Al-Mahroos G; Alsayed NA; Hasan ZA; Nawaz S; Bakhiet M
    Mol Med Rep; 2015 Nov; 12(5):7485-90. PubMed ID: 26460159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study.
    Seyhan AA; Nunez Lopez YO; Xie H; Yi F; Mathews C; Pasarica M; Pratley RE
    Sci Rep; 2016 Aug; 6():31479. PubMed ID: 27558530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters.
    García-Jacobo RE; Uresti-Rivera EE; Portales-Pérez DP; González-Amaro R; Lara-Ramírez EE; Enciso-Moreno JA; García-Hernández MH
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1092-1100. PubMed ID: 31355469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating MiRNAs of 'Asian Indian Phenotype' Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes.
    Prabu P; Rome S; Sathishkumar C; Aravind S; Mahalingam B; Shanthirani CS; Gastebois C; Villard A; Mohan V; Balasubramanyam M
    PLoS One; 2015; 10(5):e0128372. PubMed ID: 26020947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique plasma microRNA profile defines type 2 diabetes progression.
    de Candia P; Spinetti G; Specchia C; Sangalli E; La Sala L; Uccellatore A; Lupini S; Genovese S; Matarese G; Ceriello A
    PLoS One; 2017; 12(12):e0188980. PubMed ID: 29200427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.
    Higuchi C; Nakatsuka A; Eguchi J; Teshigawara S; Kanzaki M; Katayama A; Yamaguchi S; Takahashi N; Murakami K; Ogawa D; Sasaki S; Makino H; Wada J
    Metabolism; 2015 Apr; 64(4):489-97. PubMed ID: 25726255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-135 May Serve as a Novel Co-biomarker of HbA1c in Type 2 Diabetes.
    Monfared YK; Honardoost M; Sarookhani MR; Farzam SA
    Appl Biochem Biotechnol; 2020 Jun; 191(2):623-630. PubMed ID: 31833019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal miR-23a and miR-192, Potential Diagnostic Biomarkers for Type 2 Diabetes.
    Liu C; Gao Y; Wu J; Zou J
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Expression Varies according to Glucose Tolerance, Measurement Platform, and Biological Source.
    Dias S; Hemmings S; Muller C; Louw J; Pheiffer C
    Biomed Res Int; 2017; 2017():1080157. PubMed ID: 28529949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches.
    Ghoreishi E; Shahrokhi SZ; Kazerouni F; Rahimipour A
    BMC Endocr Disord; 2022 Aug; 22(1):207. PubMed ID: 35978298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes.
    Nunez Lopez YO; Garufi G; Seyhan AA
    Mol Biosyst; 2016 Dec; 13(1):106-121. PubMed ID: 27869909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.
    Ortega FJ; Mercader JM; Moreno-Navarrete JM; Rovira O; Guerra E; Esteve E; Xifra G; Martínez C; Ricart W; Rieusset J; Rome S; Karczewska-Kupczewska M; Straczkowski M; Fernández-Real JM
    Diabetes Care; 2014; 37(5):1375-83. PubMed ID: 24478399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study.
    Jiménez-Lucena R; Camargo A; Alcalá-Diaz JF; Romero-Baldonado C; Luque RM; van Ommen B; Delgado-Lista J; Ordovás JM; Pérez-Martínez P; Rangel-Zúñiga OA; López-Miranda J
    Exp Mol Med; 2018 Dec; 50(12):1-12. PubMed ID: 30598522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients.
    Baldeón R L; Weigelt K; de Wit H; Ozcan B; van Oudenaren A; Sempértegui F; Sijbrands E; Grosse L; Freire W; Drexhage HA; Leenen PJ
    PLoS One; 2014; 9(12):e115209. PubMed ID: 25500583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
    Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
    J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.